RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cerulean Pharma promotes Scott Eliasof to senior vice president

Cerulean PharmaCerulean Pharma, a clinical stage company, announced that Scott Eliasof has been promoted to the role of senior vice president and chief scientific officer.
Article continues below

READ MORE Cerulean Pharma: Oliver S. Fetzer president and CEO

Before joining Cerulean in 2007, Dr. Eliasof was the director of the Chemical Biology Platform at the Broad Institute, directing a multi-disciplinary team of professional scientists and technicians in the fields of synthetic chemistry, analytical chemistry, high-throughput screening, computational science, and software engineering.

Prior to joining the Broad Institute, Dr. Eliasof worked at Millennium Pharmaceuticals, where he managed scientific teams in cellular biology, molecular biology, neuroscience, and bioinformatics for a large-scale genomics-based drug discovery program.

Earlier in his career, Dr. Eliasof was at Neurocrine Biosciences, where he played a key role in the exploration of glutamate transporters in the field of stroke and neurological disorders.

Dr. Eliasof earned his B.S. from MIT in electrical engineering, Ph.D. from the University of California at Berkeley in neuroscience, and completed his post-doctoral fellowship at the Vollum Institute in Portland, Oregon.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy